As a provider, you are accountable for the information in this alert and when applicable, it will be incorporated into the Carelon Health of Pennsylvania Provider Manual.
2024 Provider Alerts
2023 供应商警报
- PA 18.23.10 Continuing Use of American Society of Addiction Medicine Criteria, Third Edition
- PA 17.23.09 Reminder: Retro-Authorizations Process and Policy
- PA 16.23.07 ASAM Level of Care Assessments: Who is Qualified to Conduct a Level of Case Assessment
- PA 15.23.07 Is Your Information Accurate? Please Review Your Provider Portal for Our Members
- PA 14.23.06 Return to Authorization ASAM 3.7 3.5 and 3.1
- PA 13.23.05 OHMSAS Bulletin: Confidentiality of Records Changes and Aligning with HIPAA Act of 1996
- PA 12.23.05 Office of Mental health and Substance Abuse Services Announcement: Interim Telehealth Guidance
- PA 11.23.05 Department of Drug and Alcohol Programs Reminder: Regulatory Suspensions and End of the Public Health Emergency
- PA 10.23.05 Office of Mental Health and Substance Abuse Services Announcement: Notification of HIPAA Enforcement
- PA 9.23.05 Updated Timely Filing Waiver Request Process
- PA 8.23.04 Prohibition of Billing while Operating a Motor Vehicle
- PA 7.23.04 Return to Authorizations
- PA 6.23.03 提供商计费更新
- PA 5.23.02 Beacon Health Options 正在成为 Carelon Behavioral Health
- PA 3.23.01 心理健康和药物滥用服务办公室公告 - 公告暂停信息
- PA 2.23.01 COVID-19 报告更新
- PA 1.23.01 邀请供应商参加网络研讨会：使用 Availability Essentials
- PA 4.23.02 可用性基础资源
2022 年供应商警报
- PA 9.22.12 访问、可用性和健康公平调查
- PA 8.22.12 事先授权要求更新，2022 年 9 月 1 日生效
- PA 7.22.11 毒品和酒精计划部保密指南
- PA 6.22.11 心理健康和药物滥用服务更新办公室
- PA 5.22.08 Monkeypox：提供者的重要信息
- PA 4.22.07 IBHS 提供者的授权参数和 KidNet
- PA 3.22.06 语言协助计划
- PA 2.22.03 暂时放弃及时申报要求
- PA 1.22.02 事先授权暂停，截至 2022 年 3 月 31 日
2021年提供商警报
- PA 11.21.11 Carelon COVID-19 Guidelines Update for November 2021
- PA 10.21.11 精神病和物质使用障碍患者的医学评估
- PA 9.21.11 Carelon Updated Fax Process
- PA 8.21.9 丙戊酸在育龄妇女和女孩中的使用
- PA 7.21.9 Carelon Updated Timely Filing Waiver Request Process
- PA 6.21.9 Carelon COVID-19 Guidelines: Update at 18 Months
- PA 5.21.7 Carelon Expectations for Safe Discharge from Residential Care Settings
- PA 4.21.2 Carelon Expectations for ASAM Service Alignment
- PA 3.20.8 COVID-19动态和社区护理环境准则
- PA 1.20.7 COVID-19总体照护环境指南
- PA 1.21.1用于评估和管理的CPT编码更改
2020年提供商警报
- PA 6.20.12执业医生报销
- PA 5.20.11阿片类药物治疗计划和双重合格成员
- PA 4.20.9 COVID-19 Reporting Tool for All Carelon In-Network Providers
- PA 2.20.8为精神卫生部分住院增加了15分钟代码
2019提供者警报
- PA 9.19.12口译服务
- PA 8.19.10美沙酮客户剂量
- PA 7.19.10更新的门诊授权要求
- PA 5.19.6 ACT 62流程变更
- PA 4.19.6参加分类法 已修改
- PA 3.19.5阿片类药物使用失调治疗指南
- PA 2.19.6医疗主任在住宅治疗设施中的作用
2018年提供商警报
2017年提供商警报
2016年提供商警报
2015年提供商警报
- PA 6.15.12 ICD-10和授权
- PA 5.15.12在2015年底之前重新注册/重新验证所有医疗救助计划
- PA 4.15.9授权和ICD-10编码提醒
- PA 3.15.6服务地点代码提示
- PA 1.15.4为从私人护理选择转向HealthChoices的会员申请追溯授权
2014年提供商警报
- PA 10.14.12以电子方式提交授权
- PA 9.14.10凭证和凭证– CAQH
- PA 8.14.8电子商务要求。
- ProviderConnect中的PA 7.14.7 DSM-5屏幕
- PA 6.14.4授权和追溯授权的请求
- PA 5.14.2 ICD-10索赔流程规则
- PA 4.14.2门诊药物和酒精诊所的诊断实验室服务付款
- PA 3.14.2服务授权要求
- PA 2.14.1基于家庭的提供者–旅行单位
- PA 1.14.1更新了CMS-1500表格
简体中文 
English 
Nederlands 
Español 
Français 
Italiano 
Deutsch 
Polski 
Português 
Tagalog 
Tiếng Việt 
Русский 
Հայերեն 
العربية 
فارسی 
বাংলা 
ਪੰਜਾਬੀ 
한국어 
日本語